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SUMMARY
Effect of reduction mammoplasty on the pulmonary function tests
Introduction: Bilateral breast reduction surgery is the surgical treatment of bilateral breast hypertrophy. This is one of the most 
common breast surgery requested by women, and performed by plastic surgeons. The reasons that patients want this surgery are to 
re-size sagging breasts aesthetically, and to get rid of somatic symptoms such as shoulder, chest, back, and neck pain. We believe that 
the objective positive effects of breast reduction surgery exist beside aesthetic. In our study, our aim is to elicit positive effects of 
surgery on lungs, if there are, by making pulmonary function test and carbon monoxide diffusion test before surgery and after 6 
months of surgery. 
Materials and Methods: Thirty patients agreed to participate in the study. Study is completed with 19 patients. Pulmonary function 
test and carbon monoxide diffusion test were made to all patients in preoperative and 6 months of postoperative period. Lung 
roentgenogram of all patients was performed and height, weight, body mass index were measured. Saturation level was measured.
Results: There was a meaningful increase in FEV1 and FVC values in the postoperative period in comparison with pulmonary function 
test performed in preoperative period. DLCO in postoperative period decreased meaningfully as compared to the preoperative 
period.
Conclusion: Breast reduction surgery seems to have positive effects on pulmonary function test values and relaxes patients clinically. 
Patients with big breasts should be evaluated from this perspective if they apply chest diseases clinic with shortness of breath.
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ÖZET
Meme küçültme cerrahisinin solunum fonksiyon testleri  
üzerine etkisi
Giriş: Bilateral meme küçültme cerrahisi, bilateral meme 
hipertrofisinin cerrahi tedavisidir. Kadınlar tarafından istenen, 
plastik cerrahlar tarafınca en yaygın yapılan meme 
operasyonlarından birisidir. Hastaların bu ameliyatı isteme 
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INTRoDUCTIoN
Bilateral breast reduction surgery is the surgical 
treatment of bilateral breast hypertrophy. This is one of 
the most common breast surgery requested by women, 
and performed by plastic surgeons (1). The reasons that 
patients want this surgery are to re-size sagging breasts 
aesthetically, and to get rid of somatic symptoms such 
as shoulder, chest, back, and neck pain (2). Although 
less common than other symptoms of women with 
bilateral breast hypertrophy, another important 
symptom is shortness of breath. The weight on thorax 
reduces compliance of the chest wall and improves 
breathing (3).
Studies indicate that there is an increase in quality of 
life and a decrease in symptoms on patients who 
underwent breast reduction surgery but they are more 
subjective (survey that asking patients somatic 
symptoms) and misleading to aesthetic sides of breast 
reduction surgery (4). Pulmonary function tests in 
patients who underwent breast reduction surgery are 
done but objective data can be barely reached on 
studies (1,2,5).
We believe that the objective positive effects of breast 
reduction surgery exist beside aesthetic. In our study, 
our aim is to elicit positive effects of surgery on lungs, 
if there are, by making pulmonary function test and 
carbon monoxide diffusion test (which is not performed 




All the volunteers gave an informed consent. Ethical 
approval was obtained from Ethical Board on Human 
Experiments, with the approval number 60116787-
020/57035. Thirty patients agreed to participate in 
the study. The patients with any prior lung disease 
(chronic obstructive pulmonary disease, 
bronchiectasis, bronchial asthma, interstitial lung 
disease, etc.), or who were operated from the lungs or 
chest wall, or with chest wall deformities, smoked, 
smokers or who quit currently, and with respiratory 
tract infection recently or currently or in postoperative 
period were excluded from the study. Four patients 
with bronchial asthma, 4 patients due to smoking, 2 
patients for not coming to postoperative follow-up 
and 1 patient who had lower respiratory tract infection 
in postoperative period were excluded from the 
study. Study is completed with 19 patients.
Methods
Reduction mammoplasty surgeons used the 
superomedial pedicle technique in 8 cases (42%), the 
free nipple technique in 6 cases (32%), and the 
inferior pedicle technique in 5 cases (26%) (Figure 
1,2). The amount of breast tissue removed from all 
patients was recorded.
Pulmonary function test and carbon monoxide 
diffusion test were made to all patients in preoperative 
and 6 months of postoperative period. The instrument 
used (Zan, 300 MGA, Germany) was consistent with 
American Thoracic Society the criteria. Pulmonary 
function tests were repeated at least three times and 
the best values were recorded. Diffusion test was 
measured with single-breathhold method. All tests 
were performed by the same technician in the hours 
of 9 to 12 am for to not be affected by the diurnal 
rhythm. Pulmonary function test parameters such as 
forced vital capacity percentage (FVC%), forced 
nedenleri; sarkan göğüslerini estetik açıdan düzeltmek, göğüs, sırt, omuz ve boyun ağrıları gibi somatik semptomlardan kurtulmaktır. 
Meme küçültme cerrahisinin estetik dışında objektif olumlu etkileri olduğunu düşünmekteyiz. Çalışmamızda meme küçültme cerrahisi 
olacak hastalara operasyon öncesi ve operasyondan altı ay sonrasında solunum fonksiyon testi (SFT) ve daha önce hiçbir çalışmada 
yapılmamış olan karbonmonoksit difüzyon testi yaparak, bu cerrahinin akciğer üzerine varsa olumlu etkilerini ortaya çıkarmayı 
amaçladık.
Materyal ve Metod: Otuz hasta çalışmamıza katılmayı kabul etti. On dokuz hasta ile çalışma tamamlandı. Hastaların hepsine 
preoperatif dönemde ve postoperatif dönem  altıncı ayda SFT ve karbonmonoksit difüzyon testi yapıldı. Hastaların hepsinin akciğer 
röntgenogramı çekildi ve boy, kilo, vücut kitle indeksi (kg/m2) ölçüldü. Parmaktan satürasyon ölçen cihaz ile satürasyonları ölçüldü.
Bulgular: Postoperatif dönemde uygulanan solunum fonksiyon testleri preoperatif dönemde uygulananlar ile karşılaştırıldığında FEV1 
ve FVC'de anlamlı derecede artış bulunmuştur. DLCO ise postoperatif dönemde preoperatif döneme göre anlamlı derecede azalmıştır. 
Sonuç: Meme küçültme cerrahisinin, hastaları klinik olarak rahatlatan ve solunum fonksiyon testi değerleri üzerine olumlu etkileri var 
gibi gözükmektedir. Göğüs hastalıkları polikliniğine nefes darlığı ile başvuran büyük memeli hastalar bu açıdan değerlendirilmelidir.
Anahtar kelimeler: Mamoplasti, solunum fonksiyon testleri, cerrahi, akciğer
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expiratory volume in one second of FEV% (FEV1%), 
the ratio of FEV1 to FVC (FEV1/FVC), peak expiratory 
flow rates percentage (PEF%), forced expiratory flow 
25-75% (FEF25-75%), total lung capacity (TLC), 
residual volume (RV) and diffusing capacity of the 
lungs for the carbon monoxide (DLCO) were 
measured. Lung roentgenogram of all patients was 
performed and height, weight, body mass index 
(weight/height2) (kg/m2) were measured. Saturation 
level was measured with the help of saturation 
measuring device applied to patients’ finger in the 
preoperative and postoperative period.
Statistical Analysis
Data was analyzed by the program named by 
Statistical Package for Social Science (SPSS 17.0.1 for 
Windows; SPSS Inc, Chicago, IL, 2001). Continuous 
variables are expressed as mean ± standard deviation 
and median (minimum-maximum values). 
Compliance of the normal distribution for continuous 
variables was analyzed with the Kolmogorov-Smirnov 
test. Differences between preoperative and 
postoperative measurements were evaluated with 
significance test of difference between two pairs 
(paired samples t-test) on the provision of parametric 
test assumptions.
RESULTS
The mean body mass index and age of patients are 
shown in Table 1.
Patients’ average values, which are FEV1, FVC, ratio 
(FEV1/ FVC), PEF, FEF25-75, DLCO, TLC, and RV, 
were compared in preoperative and postoperative 
periods (Table 2). While meaningful increase in FEV1 
and FVC values was detected in postoperative period, 
there was a meaningful decrease in the value of 
DLCO. There was no meaningful difference in the 
values, which are ratio (FEV1/FVC), PEF, FEF25-75, 
TLC, and RV, obtained in preoperative and 
postoperative period. Also, meaningful difference 
was not detected in the saturation values.
DISCUSSIoN
The women that underwent breast reduction surgery 
are satisfied with acquiring that surgical treatment 
and reduced neck, shoulder, and back pain was 
presented (6-10). This surgery is indicated that have 
several positive effects in studies conducted in recent 
years (11,12). All of these studies are subjective and 
based on a survey. Due to the fact that all of our 
patients were completed our study and underwent 
the surgery, they stated their satisfaction and having a 
serious reduction in their complaints. 
In our study, there was a meaningful increase in FEV1 
and FVC values in the postoperative period in 
comparison with pulmonary function test performed 
in preoperative period. This situation can be explained 
Table 1. Mean of age, body mass index, and amount of 
removed tissue
  Mean ± Std deviation
Median  
(min-max)
Age (years) 45.42 ± 12.32 48 (19-70)
BMI (kg/m2) 33.67 ± 4.10 33 (29.1-46)
Amount of removed 
tissue (g)
2190 ± 844 2060 (830-3460)
BMI: Body mass index.
Figure 1.  Patient with gigantomastia (preoperative).
Figure 2. Patient in the postoperative period (six month). 
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by relaxation in breathing as a result of increased chest 
wall compliance with breast reduction.
Goldwyn did not find a meaningful difference between 
preoperative and postoperative pulmonary function 
test in his study performed with 10 patients that 
underwent breast reduction surgery (13). Starly et al. 
found significant improvement in the values of PEF 
and peak inspiratory flows (PIF) in their study with 19 
patients (5). Sood et al. found significant improvement 
in inspiratory capacity, PEF and maximal voluntary 
ventilation value in their study of 43 patients (2). 
Iwuagwu et al. found significant improvement of FVC 
value in the intervention group in their randomized 
controlled study with 73 patients (1). Cunha et al. 
found a significant improvement in TLC and RV values 
in their study with participation of 12 patients (4). 
Kececi et al. also found a significant improvement in 
FVC value in their study with participation of 31 
patients (14). Ceber et al. found a significant 
improvement in FEV1, FVC, and FEF25-75 values in 
their study of 30 patients (15). The results in our study 
are similar to the results obtained in the study made by 
Ceber et al. and Kececi et al. 
Decrease in chest wall compliance results in a decrease 
in FVC and FEV1 values (16). Reduction mammaplasty 
has been shown to increase in chest wall compliance 
(17). It is already supported by this theory that morbid 
obesity reduces chest wall compliance (18). This can be 
explained by the increase in FVC and FEV1 after 
reduction mammaplasty in our patients.
DLCO is a clinically and commonly useful test which 
provides a measure of the transfer of gas in the lungs 
quantitatively (19). It provides essential information 
about pulmonary microcirculation (19). In our study, 
DLCO in postoperative period decreased meaningfully 
as compared to the preoperative period. This situation 
can be explained by the decrease in DLCO as a result 
of a decrease in thoracic blood volume with decrease 
venous return associated with increased transpulmonary 
pressure due to increase in chest wall compliance 
together with the breast reduction (20,21). On the other 
hand, the increase in chest wall compliance increases 
lung capacities and facilitates ventilation together. 
Therefore, an increase in diffusion can be expected. As 
far as we know, there is no other study looking at 
diffusion capacity before and after reduction 
mammaplasty. More study is needed to clarify this 
issue.
The greatest limitation of our study is the small number 
of patients due to the fact that patients remained out of 
study for several reasons. The arterial blood gas could 
not be performed due to refusing issue of patients 
particularly in postoperative period because the arterial 
blood gas is an invasive procedure despite being a more 
objective parameter. This is another limitation of our 
study.
The results of the studies made so far demonstrate that 
breast reduction surgery shows positive effects on 
pulmonary function test; however, effects on what 
parameters is still controversial.
Table 2. Pulmonary function and diffusion test in preoperative and postoperative period
             preoperative                     postoperative
  Mean ± Std deviation Mean ± Std deviation t p
FEV1 % 95.63 ± 14.33 98.05 ± 12.26 -2.27 0.035*
FVC  % 94.00 ± 14.03 98.05 ± 12.33 -3.14 0.006*
Ratio 86.63 ± 5.78 85.74 ± 5.84 2.04 0.056
PEF  % 84.63 ± 12.35 83.68 ± 10.26 0.38 0.704
FEF25_75 % 87.21 ± 20.75 86.26 ± 20.05 0.86 0.399
DLCO (mL/min/mmHg) 93.89 ± 9.21 90.53 ± 9.25 3.65 0.002*
RV % 97.58 ± 15.34 96.21 ± 17.61 0.798 0.435
TLC % 96.16 ± 10.40 97.74 ± 12.73 -0.930 0.365
FEV1: Forced expiratory volume in one second, FVC: Forced vital capacity, Ratio: FEV1/FVC, PEF: Peak expiratory flow, 
FEF25-75: Forced expiratory flow 25-75, DLCO: Diffusing capacity of the lungs for carbon monoxide, RV: Residual volume, 
TLC: Total lung capacity.
* p< 0.05 statistically meaningful difference has been found. 
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As a consequence, breast reduction surgery seems to 
have positive effects on pulmonary function test 
values and relaxes patients clinically. Patients with 
big breasts should be evaluated from this perspective 
if they apply chest diseases clinic with shortness of 
breath.
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